» Articles » PMID: 32848246

Distinct Viral Reservoirs in Individuals with Spontaneous Control of HIV-1

Abstract

Sustained, drug-free control of HIV-1 replication is naturally achieved in less than 0.5% of infected individuals (here termed 'elite controllers'), despite the presence of a replication-competent viral reservoir. Inducing such an ability to spontaneously maintain undetectable plasma viraemia is a major objective of HIV-1 cure research, but the characteristics of proviral reservoirs in elite controllers remain to be determined. Here, using next-generation sequencing of near-full-length single HIV-1 genomes and corresponding chromosomal integration sites, we show that the proviral reservoirs of elite controllers frequently consist of oligoclonal to near-monoclonal clusters of intact proviral sequences. In contrast to individuals treated with long-term antiretroviral therapy, intact proviral sequences from elite controllers were integrated at highly distinct sites in the human genome and were preferentially located in centromeric satellite DNA or in Krüppel-associated box domain-containing zinc finger genes on chromosome 19, both of which are associated with heterochromatin features. Moreover, the integration sites of intact proviral sequences from elite controllers showed an increased distance to transcriptional start sites and accessible chromatin of the host genome and were enriched in repressive chromatin marks. These data suggest that a distinct configuration of the proviral reservoir represents a structural correlate of natural viral control, and that the quality, rather than the quantity, of viral reservoirs can be an important distinguishing feature for a functional cure of HIV-1 infection. Moreover, in one elite controller, we were unable to detect intact proviral sequences despite analysing more than 1.5 billion peripheral blood mononuclear cells, which raises the possibility that a sterilizing cure of HIV-1 infection, which has previously been observed only following allogeneic haematopoietic stem cell transplantation, may be feasible in rare instances.

Citing Articles

HIV controllers: hope for a functional cure.

Deng Z, Yan H, Lambotte O, Moog C, Su B Front Immunol. 2025; 16:1540932.

PMID: 40070826 PMC: 11893560. DOI: 10.3389/fimmu.2025.1540932.


Impact of chromatin on HIV-1 latency: a multi-dimensional perspective.

Jones J, Gunderson C, Wigdahl B, Nonnemacher M Epigenetics Chromatin. 2025; 18(1):9.

PMID: 40055755 PMC: 11889793. DOI: 10.1186/s13072-025-00573-x.


Transposable elements may enhance antiviral resistance in HIV-1 elite controllers.

Singh M, Leddy S, Iniguez L, Bendall M, Nixon D, Feschotte C Genome Biol. 2025; 26(1):28.

PMID: 39988678 PMC: 11849351. DOI: 10.1186/s13059-025-03484-y.


Differences in HIV-1 reservoir size, landscape characteristics, and decay dynamics in acute and chronic treated HIV-1 Clade C infection.

Reddy K, Lee G, Reddy N, Chikowore T, Baisley K, Dong K Elife. 2025; 13.

PMID: 39976231 PMC: 11841988. DOI: 10.7554/eLife.96617.


Barcoded HIV-1 reveals viral persistence driven by clonal proliferation and distinct epigenetic patterns.

Zhang T, Shi Y, Komarova N, Wordaz D, Kostelny M, Gonzales A Nat Commun. 2025; 16(1):1641.

PMID: 39952916 PMC: 11829055. DOI: 10.1038/s41467-025-56771-4.


References
1.
Li H, Durbin R . Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009; 25(14):1754-60. PMC: 2705234. DOI: 10.1093/bioinformatics/btp324. View

2.
Jordan A, Bisgrove D, Verdin E . HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J. 2003; 22(8):1868-77. PMC: 154479. DOI: 10.1093/emboj/cdg188. View

3.
Migueles S, Connors M . Success and failure of the cellular immune response against HIV-1. Nat Immunol. 2015; 16(6):563-70. DOI: 10.1038/ni.3161. View

4.
Lukic S, Nicolas J, Levine A . The diversity of zinc-finger genes on human chromosome 19 provides an evolutionary mechanism for defense against inherited endogenous retroviruses. Cell Death Differ. 2013; 21(3):381-7. PMC: 3921586. DOI: 10.1038/cdd.2013.150. View

5.
Estes J, Kityo C, Ssali F, Swainson L, Makamdop K, Del Prete G . Defining total-body AIDS-virus burden with implications for curative strategies. Nat Med. 2017; 23(11):1271-1276. PMC: 5831193. DOI: 10.1038/nm.4411. View